Market Currents
While Pfizer's (PFE) and J&J's (JNJ) bapineuzumab Alzheimer's drug failed in a Phase III...
-
Wednesday, August 8, 2012, 9:03 AM ETWhile Pfizer's (PFE) and J&J's (JNJ) bapineuzumab Alzheimer's drug failed in a Phase III trial of people who already exhibit symptoms, scientists may yet test it on those at risk of the disease but aren't yet affected. Pfizer and J&J, though, don't yet have plans to assess bapineuzumab for this purpose.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 2 comments: